Mcaffer
Ian Cameron Gardner Mcaffer, Kent GB
Patent application number | Description | Published |
---|---|---|
20120135055 | Dry Powder Inhaler Formulations - A dpi formulation comprises a solvate of beclomethasone and is substantially free of excipient and free of carrier. The solvate particles are of size 0.5 to 10 microns and are obtained by crystallization of the steroid in the presence of ultrasound. | 05-31-2012 |
20120148638 | Steroid Solavates - A dpi formulation comprises a solvate of beclomethasone with a non-cyclic, straight or branched C | 06-14-2012 |
Ian G. Mcaffer, Calgary CA
Patent application number | Description | Published |
---|---|---|
20160101246 | APPARATUS AND METHODS FOR PRODUCING AND DELIVERING A VAPOUR MEDICAMENT - Disclosed are apparatus and methods for producing and delivering vapour medicament. An exemplary apparatus disclosed comprises: a gas inlet for receiving a gas from a source of pressurized gas; a chamber for receiving a liquid medicament therein, the chamber being in communication with the gas inlet for permitting entrance and expansion of the gas in the chamber in the presence of the liquid medicament to produce the vapour medicament; and a vapour outlet in communication with the chamber for delivering the vapour medicament. | 04-14-2016 |
Ian Gardener Cameron Mcaffer, Kent GB
Patent application number | Description | Published |
---|---|---|
20130012910 | Ampoules - An ampoule made of plastics material, for liquid or suspension pharmaceuticals, has a reservoir linked to a removable head by a channel in a neck portion. The channel has a trap, thus located between its reservoir and the head, in the form of an elongated restriction and/or a bend to trap liquid or suspension which may settle during storage, and prevent either reaching the head. | 01-10-2013 |
Ian Gardener, Cameron Mcaffer, Tatsfield GB
Patent application number | Description | Published |
---|---|---|
20100143419 | Storage of Ampoules Containing Pharmaceutical Formulations Using a Sealed Container Comprising an Oxygen Scavenger - Ampoules made of plastics material and containing 0.5 to 5 ml of a pharmaceutical formulation are sealed, together with an oxygen scavenger, within a pouch. | 06-10-2010 |
20140366491 | Storage of Ampoules Containing Pharmaceutical Formulations Using a Sealed Container Comprising an Oxygen Scavenger - Ampoules made of plastics material and containing 0.5 to 5 ml of a pharmaceutical formulation are sealed, together with an oxygen scavenger, within a pouch. | 12-18-2014 |
Ian Gardner Cameron Mcaffer, Stevanage GB
Patent application number | Description | Published |
---|---|---|
20110045086 | Steroid Nebuliser Formulation - A nebulizer formulation comprises particles of size 0.5-3 microns obtained by crystallization of beclomethasone diproprionate monohydrate in the presence of ultrasound. | 02-24-2011 |
Ian Gardner Cameron Mcaffer, Kent GB
Patent application number | Description | Published |
---|---|---|
20080257481 | Sealing of plastic containers - An ampoule contains a solution, e.g. an inhalation or injectable pharmaceutical, and an outer surface of the ampoule is coated with a metal or metal compound so as to reduce moisture egress from the ampoule and reduce contamination of ampoule contents from external sources. Labels are easily applied to the coating. | 10-23-2008 |
20100049161 | Ampoules - An ampoule made of plasties material, for liquid or suspension pharmaceuticals, has a reservoir linked to a removable head by a channel in a neck portion. The channel has a trap, thus located between its reservoir and the head, in the form of an elongated restriction and/or a bend to trap liquid or suspension which may settle during storage, and prevent either reaching the head. | 02-25-2010 |
20110131929 | Sealing of Plastic Containers - An ampoule contains a solution, e.g. an inhalation or injectable pharmaceutical, and an outer surface of the ampoule is coated with a metal or metal compound so as to reduce moisture egress from the ampoule and reduce contamination of ampoule contents from external sources. Labels are easily applied to the coating. | 06-09-2011 |
Ian G.c. Mcaffer, Kent GB
Patent application number | Description | Published |
---|---|---|
20120065258 | STABLE PROSTAGLANDIN-CONTAINING COMPOSITIONS - A pharmaceutical composition containing a prostaglandin and an alkanoic acid ester of a polyethoxylated sorbitol in an amount effective to enhance the chemical stability of the prostaglandin, and the use thereof for treating ophthalmic conditions. Also disclosed are methods for enhancing the chemical stability of a prostaglandin-containing composition by using an alkanoic acid ester of a polyethoxylated sorbitol. | 03-15-2012 |
Jeff Mcaffer, Ontario CA
Patent application number | Description | Published |
---|---|---|
20090094667 | Method and Apparatus for Automatic Determination of Authorization Requirements While Editing or Generating Code - Systems and methods are presented for automatically determining the security requirements of program code during the creation or modification of that program code and for presenting the necessary security permissions to a developer of the program code at the time of the creation or modification of the program code. A cache is established containing program code segments including library calls and application program interfaces that require security permissions at runtime. The cache also includes the security permissions associated with the stored program code segments. Program code editing is monitored in real time during the editing, and instances of edits that add, modify or delete the stored program code segments from the program code being edited are identified. The security permissions associated with the program code segments that are modified by the edits are retrieved from the cache. The retrieved security permissions are immediately presented to the developer in an interactive format that provides the developer with the ability to accept or decline the necessary changes to the security permissions. | 04-09-2009 |